The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Hepatotoxicity of Chemotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Rich, V. (1989) · Nature · doi:10.1038/338005b0 · Cited by 3,000
Rosenberg, S. A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360033032 · Cited by 1,131
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh095 · Cited by 1,038
A clinical review of bleomycin—a new antineoplastic agent
Blum, R. H., Carter, S. K., & Agre, K. (1973) · Cancer · doi:10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n · Cited by 864
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 788
KEMENY, N., DALY, J., REICHMAN, B., GELLER, N., BOTET, J., & ODERMAN, P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-459 · Cited by 649
Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., & Spalla, C. (1969) · Biotechnology and Bioengineering · doi:10.1002/bit.260110607 · Cited by 622
Methotrexate for Rheumatoid Arthritis
Kremer, J. M., Alarcón, G. S., Lightfoot, R. W., Willkens, R. F., Furst, D. E., Williams, H. J., Dent, P. B., & Weinblatt, M. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370304 · Cited by 607
Clinical toxicity of interferons in cancer patients: a review.
Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.234 · Cited by 596
Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults
ELLISON, R. R., HOLLAND, J. F., WEIL, M., JACQUILLAT, C., BOIRON, M., BERNARD, J., SAWITSKY, A., ROSNER, F., GUSSOFF, B., SILVER, R. T., et al. (1968) · Blood · doi:10.1182/blood.v32.4.507.507 · Cited by 549
Costello, J. (1971) · Medical Entomology and Zoology · Cited by 498
Fernandez, F. G., Ritter, J., Goodwin, J. W., Linehan, D. C., Hawkins, W. G., & Strasberg, S. M. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.01.024 · Cited by 465
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Self-citationChronic myelogenous leukemia: a concise update
Kantarjian, H., Deisseroth, A., Kurzrock, R., Estrov, Z., & Talpaz, M. (1993) · Blood · doi:10.1182/blood.v82.3.691.691 · Cited by 449
Povirk, L. F. (1996) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(96)00023-1 · Cited by 431
Grochow, L. B., Jones, R. J., Brundrett, R. B., Braine, H. G., Chen, T.-L., Saral, R., Santos, G. W., & Colvin, O. M. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694339 · Cited by 404
Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
Hoofnagle, J. H., Dusheiko, G. M., Schafer, D. F., Jones, E. A., Micetich, K. C., Young, R. C., & Costa, J. C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-447 · Cited by 396
Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
THALER, M., PASTAKIA, B., SHAWKER, T. H., O'LEARY, T., & PIZZO, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 395
Martin, J. K. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410200086013 · Cited by 375
Methotrexate in psoriasis: Revised guidelines
Roenigk, H. H., Auerbach, R., Maibach, H. I., & Weinstein, G. D. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)80237-8 · Cited by 357
Pancreatic Islet Cell Carcinoma: II. Results of Therapy with Streptozotocin in 52 Patients
BRODER, L. E., & CARTER, S. K. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-79-1-108 · Cited by 349
Mitomycin C: a clinical update
Bradner, W. T. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0202 · Cited by 346
Interferons in the treatment of human cancer.
Kirkwood, J. M., & Ernstoff, M. S. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.4.336 · Cited by 332
Mitoxantrone: A New Anticancer Drug with Significant Clinical Activity
SHENKENBERG, T. D., & VON HOFF, D. D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-1-67 · Cited by 305
Multiple sclerosis: Side effects of interferon beta therapy and their management
Walther, E. U., & Hohlfeld, R. (1999) · Neurology · doi:10.1212/wnl.53.8.1622 · Cited by 304
Greene, R. F., Collins, J. M., Jenkins, J., Speyer, J. L., & Myers, C. E. (1983) · PubMed · Cited by 292
Toxicity of E. coli L-asparaginase in man
Oettgen, H. F., Stephenson, P. A., Schwartz, M. K., Leeper, R. D., Tallal, L., Tan, C. C., Clarkson, B. D., Golbey, R. B., Krakoff, I. H., Karnofsky, D. A., et al. (1970) · Cancer · doi:10.1002/1097-0142(197002)25:2<253::aid-cncr2820250204>3.0.co;2-u · Cited by 290
Shulman, H. M., McDonald, G. B., Matthews, D., Doney, K. C., Kopecky, K. J., Gauvreau, J. M., & Thomas, E. D. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90911-7 · Cited by 286
Taxanes: A New Class of Antitumor Agents
Huizing, M. T., Misser, V. H. S., Pieters, R. C., ten Bokkel Huinink, W. W., Veenhof, C. H. N., Vermorken, J. B., Pinedo, H. M., & Beijnen, J. H. (1995) · Cancer Investigation · doi:10.3109/07357909509031919 · Cited by 285
Treatment of hairy cell leukemia with recombinant alpha-interferon
Quesada, Jr., Hersh, E., Manning, J., Reuben, J., Keating, M., Schnipper, E., Itri, L., & Gutterman, J. (1986) · Blood · doi:10.1182/blood.v68.2.493.493 · Cited by 278
WANLESS, I. R., GODWIN, T. A., ALLEN, F., & FEDER, A. (1980) · Medicine · doi:10.1097/00005792-198009000-00004 · Cited by 272
L-Asparaginase: Therapeutic and Toxic Effects in Patients with Neoplastic Disease
Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., & Selawry, O. S. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911062811902 · Cited by 263
Methotrexate induced liver cirrhosis
ZACHARIAE, H., KRAGBALLE, K., & SøGAARD, H. (1980) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1980.tb06553.x · Cited by 253
Sass, D. A., & Shakil, O. A. (2005) · Liver Transplantation · doi:10.1002/lt.20435 · Cited by 242
Féray, C., Samuel, D., Gigou, M., Paradis, V., David, M. F., Lemonnier, C., Reynès, M., & Bismuth, H. (1995) · Hepatology · doi:10.1002/hep.1840220411 · Cited by 241
Wanless, I. R., Ta, G., Allen, F., et al. (1980) · PubMed · Cited by 235
Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis
Weinblatt, M. E., Trentham, D. E., Fraser, P. A., Holdsworth, D. E., Falchuk, K. R., Weissman, B. N., & Coblyn, J. S. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310203 · Cited by 229
Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 220
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.
Vt, D. V., Pp, C., Owens, A. H., Gold, G. L., Mj, K., & Edmonson, J. H. (1965) · PubMed · Cited by 218
New Approaches to the Immunotherapy of Cancer Using Interleukin-2
ROSENBERG, S. A., LOTZE, M. T., & MULÉ, J. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-6-853 · Cited by 205
Kammula, U. S., White, D. E., & Rosenberg, S. A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m · Cited by 200
Kremer, J. M., Lee, R. G., & Tolman, K. G. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320202 · Cited by 199
Fatal and Nonfatal Hepatotoxicity Associated with Flutamide
Wysowski, D. K., Freiman, J. P., Tourtelot, J. B., & Horton, M. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-11-199306010-00006 · Cited by 197
Venook, A. P., Egorin, M. J., Rosner, G. L., Hollis, D., Mani, S., Hawkins, M., Byrd, J., Hohl, R., Budman, D., Meropol, N. J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2780 · Cited by 194
Essell, J. H., Schroeder, M. T., Harman, G. S., Halvorson, R., Lew, V., Callander, N., Snyder, M., Lewis, S. K., Allerton, J. P., & Thompson, J. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_1-199806150-00002 · Cited by 191
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)
Schein, P. S., O'Connell, M. J., Blom, J., Hubbard, S., Magrath, I. T., Bergevin, P., Wiernik, P. H., Ziegler, J. L., & Devita, V. T. (1974) · Cancer · doi:10.1002/1097-0142(197410)34:4<993::aid-cncr2820340404>3.0.co;2-t · Cited by 190
L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies
CAPIZZI, R. L., BERTINO, J. R., SKEEL, R. T., CREASEY, W. A., ZANES, R., OLAYON, C., PETERSON, R. G., & HANDSCHUMACHER, R. E. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-6-893 · Cited by 180
Meredith, M. J., & Reed, D. J. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90451-3 · Cited by 177
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
Hohn, D., Melnick, J., Stagg, R., Altman, D., Friedman, M., Ignoffo, R., Ferrell, L., & Lewis, B. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.1.98 · Cited by 176
Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C
García-Buey, L., García-Monzón, C., Rodriguez, S., Borque, M. J., García-Sánchez, A., Iglesias, R., DeCastro, M., Mateos, F. G., Vicario, J., Balas, A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90139-6 · Cited by 172
Drugs Five Years Later: Methotrexate
WEINSTEIN, G. D. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-2-199 · Cited by 158
Ohashi, K., Tanabe, J., Watanabe, R., Tanaka, T. Q., Sakamaki, H., Maruta, A., Okamoto, S., Aotsuka, N., Saito, K., Nishimura, M., et al. (2000) · American Journal of Hematology · Cited by 152
Lazarus, H. M., Herzig, R. H., Graham‐Pole, J., Wolff, S. N., Phillips, G. L., Strandjord, S. E., Hurd, D. D., Forman, W. B., Gordon, E. M., & Coccia, P. F. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.6.359 · Cited by 148
Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard
Saltz, L. B., Douillard, J., Pirotta, N., Alakl, M., Gruia, G., Awad, L., Elfring, G. L., Locker, P. K., & Miller, L. L. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-81 · Cited by 146
Hepatic veno-occlusive disease
Rollins, B. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90266-4 · Cited by 139
Beran, M., Estey, E. H., O'Brien, S. M., Cortes, J. E., Koller, C. A., Giles, F. J., Kornblau, S. M., Andreeff, M., Vey, N., Pierce, S. R., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2819 · Cited by 136
Hepatotoxicity of Mercaptopurine
Einhorn, M., & Davidsohn, I. (1964) · JAMA · doi:10.1001/jama.1964.03060350028007 · Cited by 134
Drug-Induced Vascular Lesions of the Liver
Zafrani, É. S. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.1983.00350030109018 · Cited by 128
Pharmacogenomics of Human UDP-Glucuronosyltransferases and Irinotecan Toxicity
Tukey, R. H., Strassburg, C. P., & Mackenzie, P. I. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.446 · Cited by 126
Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.
Hill, J. M., Loeb, E., MacLellan, A., Hill, N. O., Khan, A., & King, J. J. (1975) · PubMed · Cited by 125
Lassau, N., Leclère, J., Auperin, A., Bourhis, J. H., Hartmann, O., Valteau‐Couanet, D., Benhamou, E., Bosq, J., Ibrahim, A. M. A., Girinski, T., et al. (1997) · Radiology · doi:10.1148/radiology.204.2.9240551 · Cited by 124
THE TOXIC EFFECTS OF 6‐MERCAPTOPURINE AND RELATED COMPOUNDS
Philips, F. S., Sternberg, S. S., Hamilton, L. D., et al. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb40019.x · Cited by 123
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., & Laurie, J. A. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.12.2386 · Cited by 123
Hepatic Veno-Occlusive Disease in a Renal Transplant Patient Receiving Azathioprine
Marubbio, A. T., & Danielson, B. D. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32476-x · Cited by 118
Sherlock, S. (1995) · Gut · doi:10.1136/gut.37.3.447-b · Cited by 118
Drug-induced granulomatous hepatitis.
McMaster, K., & Hennigar, G. R. (1981) · PubMed · Cited by 114
Attal, M., Huguet, F., Rubie, H., Charlet, J.-P., Schlaifer, D., Huynh, A., Laurent, G., & Pris, J. (1993) · Blood · doi:10.1182/blood.v82.3.732.732 · Cited by 112
Antineoplastic agents and the liver
Ménard, D. B., Gisselbrecht, C., Marty, M. E., Reyes, F., & Dhumeaux, D. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90205-x · Cited by 108
Fried, M. W., Connaghan, D. G., Sharma, S., Martin, L. G., Devine, S. M., Holland, K., Zuckerman, A., Kaufman, S. L., Wingard, J. R., & BOYER, T. D. (1996) · Hepatology · doi:10.1002/hep.510240321 · Cited by 107
Ra, C., Bianco, J., Appelbaum, F. R., Buckner, C. D., Singer, J. W., Bakke, L., Singer, J. W., Bowden, R., McDonald, G., & Schubert, M. (1993) · Blood · doi:10.1182/blood.v82.7.2025.2025 · Cited by 100
Tamoxifen-associated steatohepatitis - report of three cases
Cortez‐Pinto, H., Baptista, A., Camilo, M., Costa, E. B., Valente, A. I., & de Moura, M. C. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80316-5 · Cited by 97
Lyseng-Williamson, K. A., & Jarvis, B. (2001) · Drugs · doi:10.2165/00003495-200161120-00007 · Cited by 94
Hepatic Veno-occlusive Disease Associated with Renal Transplantation and Azathioprine Therapy
Read, A. E., WIESNER, R. H., LaBRECQUE, D. R., TIFFT, J. G., MULLEN, K. D., SHEER, R. L., PETRELLI, M., RICANATI, E. S., & McCULLOUGH, A. J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-5-651 · Cited by 92
Bearman, S. I., Shen, D. D., Hinds, M., Hill, H. A., & McDonald, G. B. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03152.x · Cited by 87
Tolman, K. G., Clegg, D. O., Lee, R. G., & Ward, J. R. (1985) · PubMed · Cited by 87
Rau, R., Karger, T., Herborn, G., & Frenzel, H. (1989) · PubMed · Cited by 85
Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide
Teicher, B. A., Crawford, J. M., Holden, S. A., Lin, Y. J., Cathcart, K. N. S., Luchette, C. A., & Flatow, J. (1988) · Cancer · doi:10.1002/1097-0142(19881001)62:7<1275::aid-cncr2820620705>3.0.co;2-i · Cited by 84
Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
Dorr, R. T., Bowden, G. T., Alberts, D. S., & Liddil, J. D. (1985) · PubMed · Cited by 83
Hepatotoxicity of Mercaptopurine
Shorey, J. W. (1968) · Archives of Internal Medicine · doi:10.1001/archinte.1968.00300060056011 · Cited by 81
CASE REPORT: Fatal Cholestatic Liver Failure Associated with Gemcitabine Therapy
Robinson, K. J., Lambiase, L. R., Li, J., Monteiro, C., & Schiff, M. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1025415616592 · Cited by 80
Todros, L., Saracco, G. M., Durazzo, M., Abate, M. L., Touscoz, G. A., Scaglione, L., Verme, G., & Rizzetto, M. (1995) · Hepatology · doi:10.1002/hep.1840220506 · Cited by 80
Alexandre, J., Bleuzen, P., Bonneterre, J. M., Sutherland, W., Misset, J. L., Guastalla, J., Viens, P., Faivre, S. J., Chahine, A., Spielman, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.562 · Cited by 79
Shepherd, F. A., Beaulieu, R., Gelmon, K. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1736 · Cited by 79
Rothbarth, J., Pijl, M. E. J., Vahrmeijer, A. L., Hartgrink, H. H., Tijl, F. G. J., Kuppen, P. J. K., Tollenaar, R. A. �. �., & van de Velde, C. J. H. (2003) · British journal of surgery · doi:10.1002/bjs.4308 · Cited by 77
Methotrexate hepatotoxicity in children with leukemia
McIntosh, S., Davidson, D. L., O’Brien, R. T., & Pearson, H. A. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80587-8 · Cited by 74
Woods, W. G., Dehner, L. P., Nesbit, M. E., Krivit, W., Coccia, P. F., Ramsay, N. K. C., Kim, T. H., & Kersey, J. H. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90368-x · Cited by 72
Fisher, B., Keenan, A. M., Garra, B. S., Steinberg, S. M., White, D. E., DIBISCEGLIE, A., Hoofnagle, J. H., Yolles, P., Rosenberg, S. A., & Lotze, M. T. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1852 · Cited by 70
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration
Khan, O., Xia, Q., Bever, C. T., Johnson, K. P., PANITCH, H. S., & Dhib-Jalbut, S. S. (1996) · Neurology · doi:10.1212/wnl.46.6.1639 · Cited by 64
Cyclophosphamide-Associated Hepatotoxicity
Goldberg, J. W., & Lidsky, M. D. (1985) · Southern Medical Journal · doi:10.1097/00007611-198502000-00034 · Cited by 64
Druker, B. J., O’Brien, S. G., Cortes, J., & Radich, J. (2002) · Hematology · doi:10.1182/asheducation-2002.1.111 · Cited by 62
Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
Faggioli, P. M., Paschale, M. D., Tocci, A., Luoni, M., Fava, S., Paoli, A. D., Tosi, A., & Cassi, E. (1997) · PubMed · Cited by 60
Chemotherapeutic agents and hepatotoxicity.
Perry, M. C. (1992) · PubMed · Cited by 57
Self-citationZenz, T., Rossle, M. P., Bertz, H., Siegerstetter, V. M., Ochs, A. G., & Finke, J. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.210105.x · Cited by 57
Cyclophosphamide Hepatotoxicity in a Patient with Systemic Lupus Erythematosus
Bacon, A. M., & ROSENBERG, S. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-62 · Cited by 56
Blostein, M. D., Paltiel, O., Thibault, A., & Rybka, W. B. (1992) · PubMed · Cited by 55
Hepatoma in a Child With Methotrexate-Induced Hepatic Fibrosis
Ruymann, F. B. (1977) · JAMA · doi:10.1001/jama.1977.03280250057025 · Cited by 53
Ma, B., Yeo, W., Hui, P., Ho, W. M., & Johnson, P. J. (2002) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00003-8 · Cited by 48
Aldrighetti, L. A., Arru, M., Ronzoni, M., Salvioni, M. T., Villa, E., & Ferla, G. (2001) · PubMed · Cited by 47
Treatment of metastatic colorectal carcinoma with 5-fluorouracil by mouth
Lahiri, S. R., Boileau, G., & Hall, T. C. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:4<907::aid-cncr2820280414>3.0.co;2-9 · Cited by 46
Paugh, S. W., Stocco, G., McCorkle, J. R., Diouf, B., Crews, K. R., & Evans, W. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.126 · Cited by 46
Intestinal and liver toxicity of antineoplastic drugs.
McDonald, G. B., & Tirumali, N. (1984) · PubMed Central · Cited by 45
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
Tran, A., Housset, C., Boboc, B., Tourani, J. M., Carnot, F., & Berthelot, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90905-q · Cited by 45
Hepatotoxicity in the treatment of acute lymphoblastic leukaemia
Topley, J. M., Benson, J., Squier, M. V., & Chessells, J. M. (1979) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950070415 · Cited by 44
Hepatic injury during doxorubicin therapy.
Avilés, A., Herrera, J., Ramos, E., Ambríz, R., Aguirre, J. P. V., & Pizzuto, J. (1984) · PubMed · Cited by 43
Innocenti, F., Iyer, L., & Ratain, M. J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039050-00001 · Cited by 42
Methotrexate-induced liver abnormalities in rheumatoid arthritis.
Bridges, S. L., Alarcón, G. S., & Koopman, W. J. (1989) · PubMed · Cited by 39
Kaplan, M. M. (1990) · Hepatology · doi:10.1002/hep.1840120427 · Cited by 38
Sculier, J. P., Ghisdal, L., Berghmans, T., Branle, F., Lafitte, J. J., Vallot, F., Meert, A. P., Lemaitre, F., Steels, E., Burniat, A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1742 · Cited by 37
Camptothecin analogues: studies from The Johns Hopkins Oncology Center
Slichenmyer, W. J., Rowinsky, E. K., Grochow, L. B., Kaufmann, S. H., & Donehower, R. C. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684864 · Cited by 36
Thalidomide‐associated hepatitis: A case report
Fowler, R., & Imrie, K. (2001) · American Journal of Hematology · doi:10.1002/ajh.1062 · Cited by 34
Norris, S., Crosbie, O. M., McEntee, G., Traynor, O. J., Nolan, N. P., McCann, S., & Hegarty, J. (1997) · Transplantation · doi:10.1097/00007890-199705270-00026 · Cited by 29
Hepatic Toxicity of Drugs Used for Hematologic Neoplasia
Sznol, M., Ohnuma, T., & Holland, J. (1987) · Seminars in Liver Disease · doi:10.1055/s-2008-1040580 · Cited by 24
Cholestatic hepatitis following flutamide
Rosman, A. S., Frissora-Rodeo, C., Marshall, A. T., Reiter, B. P., & Paronetto, F. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303188 · Cited by 23
Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer
Foitl, D. R., Hyman, G. A., & Lefkowitch, J. H. (1989) · Cancer · doi:10.1002/1097-0142(19890201)63:3<438::aid-cncr2820630307>3.0.co;2-o · Cited by 23
Remick, S. C., Benson, A. B., Weese, J. L., Willson, J. K. V., Ramírez, G., Wirtanen, G. W., Alberti, D. B., Nieting, L. M., Tutsch, K. D., & Fischer, P. H. (1989) · PubMed · Cited by 18
FATAL LIVER CIRRHOSIS ASSOCIATED WITH LONG-TERM ARTERIAL INFUSION OF FLOXURIDINE
Pettavel, J., Gardiol, D., Bergier, N., & Schnyder, P. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90574-x · Cited by 17
Use of interferon in the treatment of chronic myelogenous leukemia.
Talpaz, M. (1994) · PubMed · Cited by 14
Cited by
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022) · Cancers · doi:10.3390/cancers14030627 · Cited by 458
Rubbia‐Brandt, L., Lauwers, G. Y., Wang, H., Majno, P. E., Tanabe, K., X Zhu, A., Brezault, C., Soubrane, O., Abdalla, E. K., Vauthey, J., et al. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03511.x · Cited by 312
Cancer and liver cirrhosis: implications on prognosis and management
Pinter, M., Trauner, M., Peck-Radosavljevic, M., & Sieghart, W. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000042 · Cited by 295
Effects of systemic chemotherapy on the liver
Ramadori, G., & Cameron, S. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31651-5 · Cited by 132
Metadata
- Authors
- Floyd, J., Mirza, I., Sachs, B., & Perry, M. C.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 33
- Issue
- 1
- Pages
- 50-67
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W2075816945
- Cited by
- 279
- References
- 121
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.